'Is RLS a harbinger and consequence of MS?: Striking results of the 'RELOMS-T' study'.


Journal

Multiple sclerosis and related disorders
ISSN: 2211-0356
Titre abrégé: Mult Scler Relat Disord
Pays: Netherlands
ID NLM: 101580247

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 11 11 2019
revised: 22 02 2020
accepted: 13 03 2020
pubmed: 31 5 2020
medline: 30 3 2021
entrez: 31 5 2020
Statut: ppublish

Résumé

Although studies report a high prevalence rate of restless legs syndrome (RLS) among patients with multiple sclerosis (PwMS) ranging from 13.3 to 65.1%, little is known about the causes of this relationship. To ascertain the prevalence, features and impact of RLS among PwMS a nation-wide, multicenter, prospective and a cross-sectional survey, designed to reflect all of the PwMS throughout Turkey, was conducted in 13 centers. Exploring the relationship of the two conditions could possibly contribute to the understanding of the causes of the high and wide-ranging prevalence rates and the pathophysiology of both diseases. Of the 1068 participants 173 (16,2%) found to have RLS [RLS(+)] and 895 (83,8%) did not [RLS(-)]. Among the RLS(+) 173, all but 8 patients (4,6%) were underdiagnosed in terms of RLS. More than half of the patients with RLS had 'severe' or 'very severe' RLS. The onset of RLS was before or synchronous with the onset of MS in about a half of our patients. We conclude that RLS should be meticulously investigated in PwMS and MS can be a direct cause of RLS at least in part of PwMS. Our data about the timing of the onset of MS and RLS, along with the high prevalence of RLS in PwMS suggest that the pathologic changes in the initial phases of MS can possibly trigger RLS symptoms.

Sections du résumé

BACKGROUND BACKGROUND
Although studies report a high prevalence rate of restless legs syndrome (RLS) among patients with multiple sclerosis (PwMS) ranging from 13.3 to 65.1%, little is known about the causes of this relationship.
METHODS METHODS
To ascertain the prevalence, features and impact of RLS among PwMS a nation-wide, multicenter, prospective and a cross-sectional survey, designed to reflect all of the PwMS throughout Turkey, was conducted in 13 centers. Exploring the relationship of the two conditions could possibly contribute to the understanding of the causes of the high and wide-ranging prevalence rates and the pathophysiology of both diseases.
RESULTS RESULTS
Of the 1068 participants 173 (16,2%) found to have RLS [RLS(+)] and 895 (83,8%) did not [RLS(-)]. Among the RLS(+) 173, all but 8 patients (4,6%) were underdiagnosed in terms of RLS. More than half of the patients with RLS had 'severe' or 'very severe' RLS. The onset of RLS was before or synchronous with the onset of MS in about a half of our patients.
CONCLUSION CONCLUSIONS
We conclude that RLS should be meticulously investigated in PwMS and MS can be a direct cause of RLS at least in part of PwMS. Our data about the timing of the onset of MS and RLS, along with the high prevalence of RLS in PwMS suggest that the pathologic changes in the initial phases of MS can possibly trigger RLS symptoms.

Identifiants

pubmed: 32473575
pii: S2211-0348(20)30131-0
doi: 10.1016/j.msard.2020.102055
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

102055

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interests None.

Auteurs

Serhan Sevim (S)

Mersin University, Neurology, Mersin, Turkey. Electronic address: sevimserhan33@gmail.com.

Meltem Demirkıran (M)

Çukurova University, Neurology, Adana, Turkey.

Murat Terzi (M)

Ondokuz Mayıs University, Neurology, Samsun, Turkey.

Nur Yüceyar (N)

Ege University, Neurology, İzmir, Turkey.

Bahar Taşdelen (B)

Mersin University, Biostatistics, Mersin, Turkey.

Egemen İdiman (E)

Dokuz Eylül University, Izmir, Turkey.

Murat Kürtüncü (M)

Istanbul University, Istanbul, Turkey.

Cavit Boz (C)

Karadeniz Technical University, Trabzon, Turkey.

Deniz Tuncel (D)

Sütçü İmam University, Kahramanmaras, Turkey.

Rana Karabudak (R)

Hacettepe University, Ankara, Turkey.

Aksel Siva (A)

Istanbul University, Cerrahpaşa, Istanbul, Turkey.

Abdülcemal Özcan (A)

İnönü University, Malatya, Turkey.

Münife Neyal (M)

Sanko University, Gaziantep, Turkey.

Başak Karakurum Göksel (BK)

Başkent University, Adana, Turkey.

Mehmet Balal (M)

Çukurova University, Neurology, Adana, Turkey.

Sedat Şen (S)

Ondokuz Mayıs University, Neurology, Samsun, Turkey.

Özgül Ekmekçi (Ö)

Ege University, Neurology, İzmir, Turkey.

Nevra Öksüz (N)

Mersin University, Neurology, Mersin, Turkey.

Derya Kaya (D)

Dokuz Eylül University, Izmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH